Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-096740
Filing Date
2025-10-03
Accepted
2025-10-03 17:25:16
Documents
1
Period of Report
2025-10-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2527857-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2527857-1_4seq1.xml 4 7691
  Complete submission text file 0001104659-25-096740.txt   9390
Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Issuer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CARISMA THERAPEUTICS INC. 3675 MARKET STREET, SUITE 200 PHILADELPHIA PA 19104
Business Address
Klichinsky Michael (Reporting) CIK: 0001967221 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 251375050